Products Factory | China Zvigadzirwa Vagadziri, Vatengesi

Hydrochlorothiazide

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Hydrochlorothiazide Diuretics USP/EP/CEP 16750 √ CEP 2006-011

kubvunza tsanangudzo
Folic Acid

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Folic Acid Vitamin USP/EP

kubvunza tsanangudzo
Ezetimibe

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Ezetimibe Hyperlipidemia Mumba/USP 24511 √

kubvunza tsanangudzo
Enalapril Maleate

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Enalapril Maleate Hypertension USP/EP

kubvunza tsanangudzo
Dabigatran Etexilate Mesylate

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Dabigatran Etexilate Mesylate Anticoagulant Mumba

kubvunza tsanangudzo
Daclatasvir Dihydrochloride

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Daclatasvir Dihydrochloride HCV Mumba √

kubvunza tsanangudzo
Doxycycline Monohydrate

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Doxycycline Mono Mishonga inorwisa mabhakitiriya USP/EP 18959 √

kubvunza tsanangudzo
Doxycycline Hyclate

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Doxycycline Hyclate Mishonga inorwisa mabhakitiriya USP/EP 13771 √

kubvunza tsanangudzo
Kanagliflozin

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Kanagliflozin Type 2 chirwere cheshuga Mumba √

kubvunza tsanangudzo
Chlorothiazide

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Chlorothiazide Diuretics USP/EP

kubvunza tsanangudzo
Captopril

Zita reAPI Indication Tsanangudzo US DMF EU DMF CEP

Captopril Hypertension USP/EP √ √

kubvunza tsanangudzo
Bictegravir 1611493-60-7

Zita reAPI Indication Innovator Patent Expiry Date (The US)

Bictegravir 1611493-60-7 Hutachiona hweHIV-1 Gilead Sciences Zvita 19, 2033

kubvunza tsanangudzo

<< < Previous 1 2 3 4 5 6 Zvinotevera >>> Peji 5 / 6

Zita reAPI	Indication	Tsanangudzo	US DMF	EU DMF	CEP
Hydrochlorothiazide	Diuretics	USP/EP/CEP	16750	√	CEP 2006-011

Zita reAPI	Indication	Innovator	Patent Expiry Date (The US)
Bictegravir 1611493-60-7	Hutachiona hweHIV-1	Gilead Sciences	Zvita 19, 2033